Skip to main content
. 2021 Jan 28;10:618374. doi: 10.3389/fonc.2020.618374

Figure 3.

Figure 3

Three subgroups were defined as immunity-high, immunity-medium, and immunity-low by ssGSEA scores across 33 tumor types.